Member Info for DRB83

When demand outstrips supply like it is now then contracts will usually be the way to go. Customers, governments will want to secure supply especially with Winter still to come and Omicron running wild. You would expect DA to have a sore throat from talking on the phone too much. Should be easy pickings for ncyt. I believe the main problem for ncyt is securing the raw materials. That is why I am surprised we haven't heard anything about the £30m stock write off.

I wouldn't be surprised if we get a juicy update in Jan advising that the stock has been sold and £30m recovered. Not a bad Brucey bonus, £30m is Q1 sales covered straight away.

If that's the case then we'll sell everything we can make. Problem is, are we running our machines flat out or is their a bottleneck with raw materials. When is that £30m of stock write off going to come back into play.

Well at least the gap that I was worried about closed quickly. Onwards and upwards now please

UK, small volume now, nearly all buys.
France, lots more volume, mainly sells.

As a business we have such little exposure in France that I'm starting to think the French don't actually know what we do.

Good guess Hans

This is the confusing part for me. Why spend more to get less when you can spend less and get more.

It's not that the NHS don't know about us or our q machines.

Is there red tape with us being listed and the bod deciding to stay quiet that means we don't get lots of media attention but behind the scenes the q machines are selling like hotcakes.

Maybe there's red tape around the dispute or maybe the dispute is still impacting future business with the NHS who would prefer a more expensive slower solution rather than concede to a strained relationship.

Who knows, will we ever truly know.

Why so many school settings opting for an expensive Samba or 3. If keeping kids in school is so important then surely every school setting needs access to a test machine that can process an entire class in under an hour. At the moment kids will have to isolate for upto 5 days in Scotland whilst waiting on a result. Who needs a central lab. 1 or 2 q32's say £20k and you're set for the next few years. Negatives return to class the same day.

Very inexpensive considering how much the government value our kids education. Government determined to keep kids in school they say. What is the plan then. Can't isolate a whole class for several days waiting for a negative. I suspect they'll trust there flip of a coin LTF's from China. Spend billions fuelling the Chinese economy whilst quality British equipment goes under utilised. Vote Boris, jeez.

Based on certain criteria being met which subsequently weren't.

Unfortunately the French are driving this drop. The majority of trades going through the UK are buys.

Oh Woody, just to address your comment earlier on the number of trades. Ncyt are dual listed so you would have to add them together so as I type that's 2000 trades. Can't remember what your point was now. Lol

My concern is how will governments resolve the problem. Will they increase supply or will they find ways to reduce demand which would obviously increase risk of infection. I have no confidence that the gov will do the right thing

Yep. Still TA that is 100% in play here. Fundamentals and macro economics have no bearing whatsoever at the moment.

Traders will be twitchy because ncyt struggles to hold a gain and quite often goes against TA. I'm a lth with some swing trades. I have my targets and will only get twitchy when approaching them. No where near there yet.

Woody's harmless. His deramps are built on nothing more than fresh air. My 11 year old son can do that.

Kaeren,

Found this report in Samba. Extract below:

A potential limitation of SAMBA II testing relates to financial implications as the machine costs £35,000 with test capsules costing £35 each. The financial cost implications of asymptomatic screening within maternity has not been evaluated. However, given the high infectivity of COVID-19, asymptomatic screening within a hospital setting will remain an important component so as to avoid nosocomial infection, prevent patient-to-staff infection, and to rationalise the use of full personal protective equipment. Another disadvantage is testing capacity, given that each machine can only handle only one test at a time, and each run lasting 1.5?h. Our unit has mitigated this by running 20 machines simultaneously. Additional barriers have been manufacturing enough machines, reagents and cartridges for testing. Nonetheless SAMBA II has been procured by NHS England and is being implemented in over 100 sites nationally.

https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-021-03653-4

I mean Wow. What am I missing? £35k for one machine that does 1 test per 90 mins. Oh and the conclusion of the report:

we propose the introduction of SAMBA II or other point of care testing platforms in maternity units as an accurate and acceptable test to pregnant women requiring admission.

Why would anyone opt for a Samba over a q. I'm struggling here.

Mmm Woody, you're really going to compare fundamentals. That's not the smartest move.

Spoons own the property. Yes they do in most part (not mentioning the £500k in lease liabilities) and as a result are massively in debt. A bit like me saying I own my house, but as soon as I miss a few payments then boom, the house is no longer mine. Is that the best you can do. Come on, you have to defend your share better than that.

What happens to a house of cards?

Byp is right. I could analyse Spoons all day as it's been fun but here is not the place. Good luck with your investment Woody.

Woody, not many shares go up after a profit warning so I suspect the technicals are very much in operation. What do the technicals say. Massively overbought, at the very top of a downtrend channel stretching back to May. Will it break the 50ema. If it does it will be the first time in several attempts over the last 7 months. Not looking particularly great but let's see how she blows.

You seem to like to comment on ncyt Woody so just thought I'd return the favour, that's all. Sorry if I've offended your stock picking skills.

Naewise, yes Samba appear to have had the upper hand with the NHS. Don't really understand why as when you compare the Q with the Samba I would say the q wins everytime. Quality, volume. What is the q missing that the Samba offers. Below is an example of a school that opted for the SAMBA II. Shows how on site rapid PCR testing can help in schools.

https://www.wycombeabbey.com/samba-ii-testing-machine/

UK traders were always going to get twitchy and want out this morning. A bit of buying pressure and this can motor again. If traders see a bounce from the 200ema happening then more will jump imo taking us up towards the 450. All depends of course. News would help but not expecting any until next year now.

I would hardly call honestly analysing the annual reports and macro economics deramping. If the accounts are negative and the situation negative then the outcome will be negative I'm afraid.

I missed from my analysis the raise spoons did back in April for £94m. They also received £100m in government backed Coronavirus Large Business Interruption Loan Scheme. Unfortunately, these funds don't last long when you are £900m in debt. Interest payments of £50m arn't easy to swallow when you only have £45m in the bank.

I can't see anything about any placings since so there is either one coming very soon or it will be back to the CBILS for more government funds. The numbers just don't stack up so my guess is a government loan has already been taken out. These are only short term loans so cash will need securing soon. Also the debt covenants kick back in from October 22 so there is a very real risk that if business doesn't pick up come summer that those loan covenants will come into action. That could get messy.

Spoons imo is a house of playing cards and with an already inflated mcap the risks significantly outweigh the returns but each to their own.

No egg on my face Woody. I'm comfortable in ncyt. Would much rather be generating profits with no debt.

If it's Dr Helen Lee then she is the CEO of the spin out company Diagnostics In The Real World who developed the Samba II PCR machine. So it's most definitely Samba

Yes scaffers but it's the rules behind how the triaging is done that is the worrying part. I.e. we have 1 ICU bed boss but 3 patients that need it. Ah right, well let's go through the checklist and see who wins. It's the checklist that worries me. If it's such a concern then throw some bloody tax money at it and get more beds and machinery. It should never come down to a checklist that determines who lives and who dies.